Rescription
Thomas Lundquist, MD, currently serves as the Chief Executive Officer at HealthNEXT, leading a population health advisory and human capital platform dedicated to enhancing employee health and wellbeing. In addition to this role, Thomas Lundquist is the President of Vital Insights LLC, which provides consultative services focused on Healthcare Transformation and value models for C-suite executives. Other positions held by Thomas Lundquist include Executive Advisor at ECHO, Strategic Advisor for AposHealth and Rescription, and Advisor at the Health Growth Advisory Network. Thomas Lundquist previously served as Chief Medical Officer at ValueHealth LLC and Highmark Health, as well as SVP & Chief Medical Officer at Optima Health, and Chief Clinical Integration Officer at Integrated Solutions Health Networks. Academic credentials include an M.D. from The Johns Hopkins University School of Medicine, a Master’s in Medical Management from Carnegie Mellon University, and a Bachelor of Science in Premedicine from Penn State University.
This person is not in any teams
Rescription
Rescription is a next-generation full PBM solution that leverages health system partnerships to deliver pharmacy benefits at net costs 20-40% lower than any alternative, without the need to limit patient drug choice. Rescription fully supports the change from a traditional PBM to its model, including claim servicing, administrative, and retail network infrastructure. It leverages your pharmacy, specialists, and 340B purchasing capabilities to create a preferred network for patients and their families. All drugs are passed through at their sourced price and Rescription simply charges a subscription-based fee per member, meaning that Rescription's only financial incentive is to save its clients and partners money on their prescription drug costs. Health systems can learn more about prescription drug savings opportunities at www.rescription.com.